Latest News & Features
Americas
Zimmer Biomet is suing rival dental implant manufacturer Integrated Dental Systems, claiming that it markets “cheap” replacement parts for Zimmer’s implant systems. 12 August 2021
Americas
The Brazilian Senate Plenary has approved a bill that will allow President Bolsonaro to waive patent protections for COVID-19 vaccines. 12 August 2021
article
When the smallest error in translation can result in a patent’s rejection or invalidation, it is important to be mindful of the key steps to successfully translate a patent and the impact it can have if they are not considered. 12 August 2021
Americas
The US Court of Appeals for the Federal Circuit has reinstated a $235 million verdict against Teva in a split decision which could have major implications for skinny label generics. 10 August 2021
Europe
In the final article of a four-part series, Sophie Topham of Marks & Clerk discusses the supplementary protection certificate manufacturing waiver. 10 August 2021
Medtech
The US Court of Appeals for the Seventh Circuit has upheld a preliminary injunction from an Illinois court that blocked medical device maker Aegis Spine from selling its spinal implant. 10 August 2021
Generics
Pharmaceutical companies Shionogi and Duchesnay have filed a second lawsuit against Hetero labs, claiming that the company infringed two additional patents related to Osphena—a treatment for vaginal pain during sex. 5 August 2021
Generics
Takeda Pharmaceuticals is the target of a proposed class action that alleges the pharma giant paid to keep a generic anti-constipation drug off the market. 5 August 2021
Generics
In the third article of a four-part series on experimental use exemptions from infringement in the UK, Sophie Topham of Marks & Clerk considers the expansion of the original exemption. 5 August 2021
Big Pharma
The US Federal Trade Commission has dropped its remaining claim in a lawsuit against AbbVie and Besins Healthcare, after the US Supreme Court declined to rule that consumers had a right to be compensated by the companies. 3 August 2021